| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ |
|---|---|---|---|---|
| Revenue | — | — | — | — |
| Cost of Revenue | — | — | — | — |
| Gross Profit | — | — | — | — |
| R&D Expense | — | — | — | — |
| SG&A Expense | — | — | — | — |
| Operating Income | — | — | — | — |
| Net Income | $0.6B | $0.6B | $0.8B | $0.5B |
| EPS (Basic) | $1.24 | $1.53 | $2.03 | $1.18 |
| EPS (Diluted) | $1.24 | $1.53 | $2.03 | $1.18 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ |
|---|---|---|---|---|
| Total Assets | $17.2B | $13.9B | $13.5B | $13.6B |
| Current Assets | — | — | — | — |
| Cash & Equivalents | — | — | — | — |
| Total Liabilities | $9.8B | $7.9B | $7.5B | $7.7B |
| Current Liabilities | — | — | — | — |
| Stockholders' Equity | $7.4B | $6.0B | $6.0B | $5.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ |
|---|---|---|---|---|
| Operating Cash Flow | $1.7B | $0.2B | $1.1B | $0.2B |
| Investing Cash Flow | — | — | — | — |
| Capital Expenditures | — | — | — | — |
| Financing Cash Flow | $-1.7B | $-0.3B | $-0.9B | $-0.2B |